Latest Developments in Europe Craniomaxilofacial Devices Maket

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Europe Craniomaxilofacial Devices Maket

  • Healthcare
  • May 2025
  • Europe
  • 150 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In March 2024, KLS Martin Group announced the new 5,100 m² production facility in Jacksonville, Florida. It increases production capacity for custom-made craniomaxillofacial implants. The investment was USD 38 million, integrating state-of-the-art additive manufacturing technologies to accommodate rising demand for individualized implants and to create 180 new jobs contributing to the regional economy.
  • In February 2024, According to Materialise, the company released its Personalized TMJ Total Arthroplasty System on February 22, 2024. In a clinical study, one year post-surgery, the system, featuring implants, guides, and digital planning, achieved a 100% success rate. Patients have shown significant improvement in pain levels, quality of life, and their ability to eat.
  • In December 2023, Stryker Corporation, one of the world’s leading medical technology companies, announced the execution of a binding offer to Menix to acquire SERF SAS, a France-based joint replacement company.
  • In November 2022: Zimmer Biomet Inc., a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the Persona OsseoTi Keel Tibia for cementless knee replacement.
  • In February 2022, Johnson & Johnson Medical Devices Companies announced that DePuy Synthes (a division of Johnson & Johnson) has acquired CrossRoads Extremity Systems, a Tennessee-based foot and ankle company that provides a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for lower extremity indications